Fox Chase Cancer Center News

PHILADELPHIA (November 2, 2021)—Marcin Chwistek, MD, FAAHPM, director of the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center, will be speaking virtually at the Hospice Care Professionals Association Conference being held in Moscow November 2-3.

PHILADELPHIA (October 25, 2021)—A multi-institutional retrospective analysis conducted by researchers at Fox Chase Cancer Center has found that early stage prostate cancer patients treated with moderately hypofractionated intensity-modulated radiation therapy or proton beam radiation therapy had low risk of serious late genitourinary and gastrointestinal complications.

PHILADELPHIA (October 24, 2021)—In a recent retrospective study, researchers at Fox Chase Cancer Center found anorectal cancer patients reirradiated with pulsed low-dose-rate radiotherapy had reduced toxicity and improved outcomes when compared with patients treated with twice-daily radiotherapy.

PHILADELPHIA (October 19, 2021)—Fox Chase Cancer Center’s Edna “Eti” Cukierman, PhD, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, has been named a senior editor for Cancer Research Communications, a new online journal.  

PHILADELPHIA (October 15, 2021)—Recent findings from a study conducted at Fox Chase Cancer Center could help pave the way for more effective treatment of aggressive brain tumors, researchers say.

PHILADELPHIA (October 15, 2021)—The Pancreatic Cancer Cure Foundation will present a donation of $28,500 to the lab of Edna “Eti” Cukierman, PhD, a co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, on Monday, October 18, to fund further research into detecting and treating pancreatic cancer

PHILADELPHIA, (October 14, 2021)—Fox Chase Cancer Center researcher Alfonso Bellacosa, MD, PhD, was recently named a recipient of the first ever 2021 Mid-Atlantic Italian American Medical Awards.

PHILADELPHIA (October 14, 2021)—Cristina Uribe-Alvarez, PhD, a postdoctoral associate in the lab of Jonathan Chernoff, MD, PhD, at Fox Chase Cancer Center recently received a $75,000 one-year grant from the F.M. Kirby Foundation to continue her study on RAC1 mutations in melanoma.